Solid form of pyrazolopyridine compound
AssigneeSunshine Lake Pharma Co., Ltd.
InventorsShouzhu LIAO, Weijie FAN, Zhongqing WANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeSunshine Lake Pharma Co., Ltd.
InventorsShouzhu LIAO, Weijie FAN, Zhongqing WANG
Estimating the term…
A novel crystalline form or amorphous of formula (I) and preparation method thereof are disclosed in present invention, wherein the novel crystalline form is substantially pure crystalline form I, form II, form III or form IV. The novel crystalline forms disclosed herein have good solubility, low hydroscopicity and good stability at high temperature (60° C.), high humidity (RH is 90%±5%) and/or under light (4500+/−500 Lux), which benefit for storage, meet the requirements of drug stability and therefore, making formula (I) suitable for formulation preparation and with high bioavailability.
A crystalline form of compound of formula (I), wherein the crystalline form is form I, form II, form III or form IV
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Amorphous form of compound of formula (I), wherein the X-ray powder diffraction pattern is substantially as depicted in FIG. 9.
(canceled)
Dependencies are inferred from the claim text.